Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands.

Probert F, Yeo T, Zhou Y, Sealey M, Arora S, Palace J, Claridge TDW, Hillenbrand R, Oechtering J, Kuhle J, Leppert D, Anthony DC

13 December 2022

Journal article

Journal:

Frontiers in immunology

Volume:

Frontiers

Switzerland

1095038

[This corrects the article DOI: 10.3389/fimmu.2021.811351.].

Keywords:

metabolomics (OMICS)

proteomics

diagnosis

biomarker

oligoclonal band

multiple sclerosis (MS)

DOI